KATHERINE MCGRAW: Open Payments
NPI 1144539479 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 12 payments from 8 companies in 2025. Trend: 2023 $87 · 2024 $88 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Gilead Sciences, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| ViiV Healthcare Company | 1 | $14 |
Products named: UZEDY, ZERBAXA, PIFELTRO, TEFLARO, VOWST, REBYOTA, NUZYRA, DOVATO.
Industry payments across OH — which companies pay providers there.
